Kevin Li
InvestorPartner at Frazier Life Sciences Β· Principal at Frazier Healthcare Partners
Palo Alto
About
Kevin Li is a Partner at Frazier Life Sciences, which he joined in 2021, investing in public and late-stage private companies through the Frazier Life Sciences Public Fund. He previously worked as a consultant at McKinsey & Company on corporate strategy, growth, and M&A in hospital services and pharmaceuticals, and was a resident physician in Internal Medicine at Stanford. He holds an M.D. from Stanford University and a B.S. in Molecular Biophysics and Biochemistry from Yale University.
ContactΒ· self-published, not guessed
Invests in
Biotech
Experience
- Frazier Life SciencesPartnercurrent2021 β presentPalo Alto, California, United States
- Stanford Health CareResident Physician - Internal Medicine2020 β 2021Stanford, California, United States
- Frazier Healthcare PartnersSummer Associate2019
- Acuta Capital Partners, LLCSummer Associate2018
- McKinsey & CompanyBusiness Analyst2014 β 2016New York City Metropolitan Area
- Yale University School of MedicineResearch Assistant2011 β 2014New Haven, CT
Deals Β· 2
35PharmaLed round
Scorpion TherapeuticsLed round
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Board seats
Angitia BiopharmaceuticalsGondolabio
Per the firm's website.
Colleagues at Frazier Life Sciences
Frequently asked questions
- Who is Kevin Li?
- Kevin Li is a Partner at Frazier Life Sciences, which he joined in 2021, investing in public and late-stage private companies through the Frazier Life Sciences Public Fund. He previously worked as a consultant at McKinsey & Company on corporate strategy, growth, and M&A in hospital services and pharmaceuticals, and was a resident physician in Internal Medicine at Stanford. He holds an M.D. from Stanford University and a B.S. in Molecular Biophysics and Biochemistry from Yale University.
- Where does Kevin Li work?
- Kevin Li is Partner at Frazier Life Sciences.
- What does Kevin Li invest in?
- Kevin Li invests in Biotech.
- What boards does Kevin Li sit on?
- Kevin Li holds tracked board seats at Angitia Biopharmaceuticals, Gondolabio.
- What companies has Kevin Li invested in?
- Investments tracked here include 35Pharma, Scorpion Therapeutics.
- Where did Kevin Li go to school?
- Kevin Li studied at Stanford University School of Medicine (M.D.); Yale University (B.S., Molecular Biophysics and Biochemistry).
- Does Kevin Li lead rounds?
- Yes β Kevin Li has led 2 tracked investments.
Same school
Also attended Stanford University School of Medicine83
+ 77 more
Shared employers
Also worked at Stanford Health Care36
+ 30 more
Also worked at Frazier Healthcare Partners27
+ 21 more
Also worked at Acuta Capital Partners, LLC1
Also worked at McKinsey & Company1,548
+ 1,542 more





































